BetterLife Pharma (BETRF) Operating Expenses (2010 - 2026)

BetterLife Pharma has reported Operating Expenses for 17 years, with the latest figure at $33367.6 in Q2 2026.

• On a quarterly basis, Operating Expenses fell 28.99% year-over-year to $33367.6 in Q2 2026; TTM through Apr 2026 was $995529.2, a 49.83% decrease from a year earlier, with the FY2026 full-year figure at $1.2 million, down 68.19% from the prior year.
• Operating Expenses was $33367.6 for Q2 2026 at BetterLife Pharma, down from $379762.0 in the prior quarter.
• The five-year high for Operating Expenses was $3.4 million in Q4 2022, with the low at $33367.6 in Q2 2026.
• Average Operating Expenses over 5 years is $972093.2, with a median of $625082.1 recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses jumped 176.95% in 2024, then plunged 97.26% in 2025.
• Over 5 years, Operating Expenses stood at $3.4 million in 2022, then tumbled by 81.54% to $631648.0 in 2023, then retreated by 13.21% to $548219.9 in 2024, then sank by 30.73% to $379762.0 in 2025, then slumped by 91.21% to $33367.6 in 2026.
• The last three Operating Expenses figures came in at $33367.6 (Q2 2026), $379762.0 (Q3 2025), and $46988.7 (Q2 2025), per Business Quant data.